[Evaluation of myocardial perfusion in patients with coronary slow flow by myocardial contrast echocardiography]

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Apr;41(4):293-6.
[Article in Chinese]

Abstract

Objective: To explore myocardial perfusion of patients with coronary slow flow (CSF) using myocardial contrast echocardiography.

Methods: Myocardial contrast echocardiography was performed in coronary artery angiography diagnosed CSF patients (n = 20) and control patients (n = 20). The images at baseline and after low dose dobutamine stress test were analyzed by automatic tracking software and the maximal amplitude score A, the mean ascending slope of the curve β and the product of A×β were measured. The reserve of A×β was also calculated. Electrocardiogram at rest and at each stage of dobutamine stress test was obtained simultaneously.

Results: At baseline, the A [(6.85 ± 2.99) dB vs. (7.01 ± 3.49) dB], β[(0.59 ± 0.33)/s vs. (0.61 ± 0.38)/s] and A×β [(3.48 ± 1.46) dB/s vs. (3.31 ± 0.96) dB/s] values were similar between CSF group and control group (all P > 0.05). After dobutamine stress test, both β and A×β were significantly increased in two groups. The β [(0.89 ± 0.42)/s vs. (1.31 ± 0.54)/s, P < 0.01] and A×β [(5.82 ± 2.69) dB/s vs. (8.07 ± 2.76)dB/s, P < 0.05] in CSF group were significantly lower than in control group. Electrocardiogram of all the subjects was normal at rest, but the electrocardiogram positive rate was significantly higher in CSF group than in control group after dobutamine stress test (12% vs. 2%, 60% vs. 10%, P < 0.01).

Conclusions: Dobutamine stress test could induce myocardial perfusion abnormalities in patients with coronary slow flow phenomenon.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Case-Control Studies
  • Coronary Circulation* / drug effects
  • Dobutamine
  • Echocardiography / methods*
  • Exercise Test
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Dobutamine